Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Pregnancy in Polycystic Ovary Syndrome II
- Status
- COMPLETED
- Phase
- PHASE3
BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic
- Status
- COMPLETED
- Phase
- PHASE2
Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
- Status
- UNKNOWN
- Phase
- PHASE3
Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy
- Status
- COMPLETED
- Phase
- N/A
Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.
- Status
- TERMINATED
- Phase
- PHASE2
Letrozole vs. Clomiphene Citrate in Patients With Anovulatory Infertility
- Status
- COMPLETED
- Phase
- PHASE3
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Breast Cancer Prevention by Letrozole in High Risk Women
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2